Healthcare Policy Changes in Osteoporosis Can Improve Outcomes and Reduce Costs in the United States.
E Michael LewieckiJesse D OrtendahlJacqueline Vanderpuye-OrgleAndreas GrauerJorge ArellanoJeffrey LemayAmanda L HarmonMichael S BroderAndrea J SingerPublished in: JBMR plus (2019)
In the United States, osteoporosis affects over 10 million adults, has high societal costs ($22 billion in 2008), and is currently being underdiagnosed and undertreated. Given an aging population, this burden is expected to rise. We projected the fracture burden in US women by modeling the expected demographic shift as well as potential policy changes. With the anticipated population aging and growth, annual fractures are projected to increase from 1.9 million to 3.2 million (68%), from 2018 to 2040, with related costs rising from $57 billion to over $95 billion. Policy-driven expansion of case finding and treatment of at-risk women could lower this burden, preventing 6.1 million fractures over the next 22 years while reducing payer costs by $29 billion and societal costs by $55 billion. Increasing use of osteoporosis-related interventions can reduce fractures and result in substantial cost-savings, a rare and fortunate combination given the current landscape in healthcare policy. © 2019 The Authors. JBMR Plus published by Wiley Periodicals, Inc. on behalf of American Society for Bone and Mineral Research.
Keyphrases
- healthcare
- bone mineral density
- public health
- postmenopausal women
- mental health
- polycystic ovary syndrome
- climate change
- pregnancy outcomes
- randomized controlled trial
- risk assessment
- skeletal muscle
- systematic review
- single cell
- insulin resistance
- drug induced
- body composition
- cervical cancer screening
- soft tissue
- bone regeneration